Perceptions of French general practitioners and patients regarding dextropropoxyphene withdrawal: a qualitative study.

ABSTRACT:

Objectives

Dextropropoxyphene (DXP), a step 2 analgesic commonly prescribed in France, was withdrawn from the French market in 2011 following a European decision due to its poor risk-benefit ratio. The purpose of this study was to explore the perceptions of French general practitioners (GPs) and patients regarding DXP withdrawal.

Design

Qualitative study based on 26 individual semi-structured interviews.

Setting

Rhône-Alpes region of France.

Participants

Thirteen patients and 13 GPs.

Methods

Interviews were conducted to collect data concerning the status of DXP, its efficacy and safety, the conditions of DXP's withdrawal and its potential impact. The transcripts were analysed using NVivo software.

Results

DXP was a very popular drug among both pat

SUBMITTER: Combier A 

PROVIDER: S-EPMC6157533 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature